Distal femoral stem-bone anchorage of a cementless revision total hip arthroplasty: evaluation of 14 patients by CT.

BACKGROUND AND PURPOSE: According to the manual of the cementless Link MP reconstruction prosthesis, a distal femoral stem-bone anchorage of at least 80 mm is necessary to gain implant stability. There have been no in vivo studies showing that this distance is either achieved in clinical practice or needed for clinically satisfying results. Thus, we assessed the femoral stem-bone anchorage of the MP prosthesis using CT. METHODS: 14 patients with the MP stem were evaluated by CT scans at a median follow-up time of 12 months postoperatively. Femoral stem-bone anchorage was defined as adequate if 50% of the stem flutes or more had cortical bone contact. The length of anchorage was derived from the number of slices with adequate anchorage. Clinical outcome was assessed with VAS for pain and Harris hip score (HHS), both at 1 and 5 years of follow-up. RESULTS: The median length of stem-bone anchorage was 33 mm (interquartile range 10-60), which was shorter than recommended (p = 0.002). Still, at the 1-year control, all patients were fully weight-bearing and only 1/14 complained about mild thigh pain. 7/14 patients did not experience any pain in the affected hip. The patients had a median of 85 points in the HHS. The clinical outcome at 5 years was unchanged. INTERPRETATION: We found that it can be difficult to achieve a stem-bone anchorage of at least 80 mm for the MP Link prosthesis. However, this does not appear to be necessary to obtain stability and to achieve clinically satisfying results.

Significance of mesorectal volume in staging of rectal cancer with magnetic resonance imaging and the assessment of involvement of the mesorectal fascia.

The aim was to study the influence of mesorectal volume, as estimated by magnetic resonance imaging (MRI), that is to be removed during total mesorectal excision (TME), on the accuracy of the first preoperative MRI of rectal cancer compared to histopathology, and its correlation to locoregional prognostic factors. A total of 267 rectal cancer patients from a multinational study (MERCURY or MRI equivalence study) had their mesorectal volume retrospectively estimated by researchers without knowledge of the assessments made by the radiologist or the pathologist. The evaluations made by the pathologist and the radiologist were then compared, including T- and N-staging, assessment of extent of extramural tumor invasion (the largest portion of the tumor beyond the muscularis propria or EMI) and distance to mesorectal fascia; the discrepancies in the results were correlated to the mesorectal volume. T- or N-staging accuracy by MRI and the difference between the EMI as measured by the pathologist and the radiologist were not dependent on individual mesorectal volume. There was no correlation between assessment of involvement of mesorectal fascia or local neighboring organs by MRI and histopathology with mesorectal volume. Mesorectal volume does not affect locoregional prognostic factors or the accuracy of local staging of rectal cancer.